Commission Implementing Regulation (EU) 2019/2007Show full title

CHAPTER 30 U.K. Pharmaceutical products

General remarks U.K.

Finished medicinal products, which are not covered by Regulation (EC) No 1069/2009 and (EU) No 142/2011, are excluded from the list. Intermediate products are included.

In heading 3001 (glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included) only animal derived products of subheadings 3001 20 and 3001 90 are relevant for official controls. Refer to the following specific requirements in Annex XIV to Regulation (EU) No 142/2011:

1.

Row 2 of Table 2 in Section 1 of Chapter II for blood products for technical products excluding from equidae, and

2.

Row 3 of Table 2 in Section 1 of Chapter II for blood and blood products from equidae, and

3.

Row 14 of Table 2 in Section 1 of Chapter II for animal by-products for the manufacture of pet food other than raw pet food and of derived products for uses outside the feed chain.

In heading 3002 (human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products) only subheadings 3002 12 and 3002 90 are relevant for official controls. Human blood of 3002 90 10 and vaccines of subheadings 3002 20 and 3002 30 do not need to be subjected to official controls.

CN code	Description	Qualification and explanation
(1)	(2)	(3)
3001 20 90	Extracts of glands or other organs or of their secretions, other than of human origin	All; covers a product acting as a replacement for maternal colostrum and used in the feeding of calves.
ex 3001 90 91	Animal substances prepared for therapeutic or prophylactic uses: heparin and its salts	All animal products, which are destined for further processing, in accordance with Article 34(1) of Regulation (EC) No 1069/2009, for the manufacture of the derived products referred to in points (a) to (f) of Article 33 of that Regulation.
3001 90 98	Other animal substances than heparin and its salts prepared for therapeutic or prophylactic uses, not elsewhere specified or included	All. In addition to the glands and other organs mentioned in the Harmonized System Explanatory Notes to heading 3001, (A), this subheading covers the hypophysis, the suprarenal capsules and the thyroid gland; except those specified in Article 33 of Regulation (EC) No 1069/2009.
ex 3002 12 00	Antisera and other blood fractions	Animal derived products only. Excludes finished medicinal products for the final consumer. Excludes antibodies and DNA. Under heading 3002, specific requirements are set out for animal by-products covered by Table 2 in Section 1 of Chapter II of Annex XIV to Regulation (EU) No 142/2011 and specified in the following Rows: Row 2: blood products other than from equidae; Row 3: blood and blood products from equidae.
3002 90 30	Animal blood prepared for therapeutic, prophylactic or diagnostic uses	All
ex 3002 90 50	Cultures of micro organisms	Only pathogens and cultures of pathogens for animals.
ex 3002 90 90	Other	Only pathogens and cultures of pathogens for animals.
ex 3006 92 00	Waste pharmaceuticals	Animal derived products only. Pharmaceutical waste, pharmaceutical products, which are unfit for their original intended purpose.